Sonnet Biotherapeutics has received shareholder approval to merge with Hyperliquid Strategies Inc

2025-12-02 22:26:45

Collection

According to market news, Nasdaq-listed biotech company Sonnet Biotherapeutics has received shareholder approval to merge with Hyperliquid Strategies Inc.

Previously, it was reported that Hyperliquid Strategies submitted an S-1 filing to raise up to $1 billion, which may be used to purchase HYPE tokens.

Source

Risk warning

2026-04-09 17:18

Changxin Technology: Online investors gave up on subscribing to 6.5862 million shares

2026-07-21 19:33

Deutsche Bank: Concerns about Microsoft's AI investment have been overly reflected; Azure's growth rate may reach 41%

2026-07-21 18:24

RootData stock derivatives exchange ranking: Binance, MEXC, and Bybit occupy the top three positions, while Bitget and OKX drop to fourth and sixth respectively

2026-07-21 18:03